Abstract: One aspect of the present application relates to a storage stable pharmaceutical composition comprising a sulfated glycosaminoglycan having an average molecular weight ranging from 3,000 to 15,000 Daltons, and a pharmaceutical carrier, where the pharmaceutical carrier is mixed with the sulfated glycosaminoglycan, as well as this composition's use in a method of treating a subject for a medically observable improvement. Another aspect of the present application relates to a process for producing a storage stable purified sulfated glycosaminoglycan.

Abstract: Various devices, systems and methods such as photonductive semiconductor switches (PCSS) and optically addressable light valves (OALVs) include a photoconducting ?-Ga2O3 layer having a transition metal (TM) doped region formed by diffusion of transition metal into a ?-Ga2O3 substrate. The diffusion of the TM into the ?-Ga2O3 substrate provides for the controlled concentration and thickness of the doped TM region that is integrated into the bulk ?-Ga2O3 substrate.

Abstract: Surfaces of a structure are treated from a walkway within an enclosure suspended from the structure. The enclosure has a downwardly-converging cross section terminating in a vacuum conveyor for collecting and removing particles accumulating from the blasting process. The enclosure is preferably provided in modules. The vacuum conveyor removes the particulate material for transfer to conventional separating and re-cycling equipment. the enclosure and walkway are moveably suspended from transverse guideways secured to the structure.